Highlight Therapeutics Funding: $49M Raised, Series B (2021)
Highlight Therapeutics is based in Valencia, Spain. It has raised $49M in total funding. Latest round: Series B.
Highlight Therapeutics funding overview
Highlight Therapeutics is based in Valencia, Spain. Highlight Therapeutics has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Highlight Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Columbus Life Science, Advent Life Science. 2 distinct backers are named across the disclosed rounds.
Highlight Therapeutics at a glance
Total raised
$49M
Latest round
Series B
Latest round date
January 2021
Headquarters
Valencia, Spain
Notable investors
Columbus Life Science, Advent Life Science
Frequently asked about Highlight Therapeutics funding
How much has Highlight Therapeutics raised?
Highlight Therapeutics has raised $49M in total disclosed funding across the rounds on record.
Who has invested in Highlight Therapeutics?
Columbus Life Science, Advent Life Science are named among the investors backing Highlight Therapeutics.
What was the latest Highlight Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Highlight Therapeutics based?
Highlight Therapeutics is based in Valencia, Spain.
When did Highlight Therapeutics last raise?
The last disclosed Highlight Therapeutics round closed in January 2021 at Series B.
Highlight Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Valencia below to benchmark round size and investor mix.
